These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5877602)

  • 1. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M; Cottet J; Etienne J; Loeper J
    Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H; Jaillard J
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypolipidemic agents--newly approved.
    Duncan GG
    Pa Med; 1967 Aug; 70(8):75-6. PubMed ID: 6073724
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 7. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B; Monnier J
    Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of atromide on some indices of the lipid metabolism in hypercholesterinemic patients].
    Baranova LV
    Kardiologiia; 1965; 5(4):65-6. PubMed ID: 5880736
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical-experimental studies on lipid metabolism using Regelan].
    Hammerl H
    Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
    [No Abstract]   [Full Text] [Related]  

  • 11. Divergent effects in the treatment of hyperlipemia.
    Slowe IA; Carter AC; Feldman EB
    Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
    [No Abstract]   [Full Text] [Related]  

  • 12. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of atromid or CPIB treatment with and without androsterone in hyperlipemia (110 therapeutic trials in 2 years)].
    de Gennes JL; Maunand B; Salmon ; Laudat P; Truffert J
    Bull Mem Soc Med Hop Paris; 1965 Apr; 116(8):759-84. PubMed ID: 5834264
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of primary hyperlipemias].
    Schlierf G; Kahlke W
    Dtsch Med Wochenschr; 1969 Feb; 94(7):329-32. PubMed ID: 5762992
    [No Abstract]   [Full Text] [Related]  

  • 15. [CPIB: a hypolipidemic agent. Study of 20 patients].
    Verdy M
    Union Med Can; 1966 Sep; 95(9):1049-52. PubMed ID: 5913817
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S; Esilä R; Tuovinen E
    Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
    [No Abstract]   [Full Text] [Related]  

  • 17. Trial of "Atheran" and "Atromid-S" in atherosclerosis.
    Barnett AJ; Carson V
    Med J Aust; 1966 Jun; 1(23):965-70. PubMed ID: 5939995
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of essential hypercholesteremia?].
    Schettler G
    Dtsch Med Wochenschr; 1968 Sep; 93(37):1779. PubMed ID: 5681549
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
    Laubinger G
    Med Klin; 1968 Jan; 63(4):139-42. PubMed ID: 5670163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.